MTOR and cancer: FAK mediates signalling from the ECM to the cytoplasm via several pathways, including the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) pathway that promotes cancer cell survival.92